BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dulger AC, Suvak B, Gonullu H, Gonullu E, Gultepe B, Aydın İ, Batur A, Karadas S, Olmez Ş. High prevalence of chronic hepatitis D virus infection in Eastern Turkey: urbanization of the disease. Arch Med Sci 2016;12:415-20. [PMID: 27186189 DOI: 10.5114/aoms.2015.52030] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Hayashi T, Takeshita Y, Hutin YJ, Harmanci H, Easterbrook P, Hess S, van Holten J, Oru EO, Kaneko S, Yurdaydin C, Bulterys M. The global hepatitis delta virus (HDV) epidemic: what gaps to address in order to mount a public health response? Arch Public Health 2021;79:180. [PMID: 34663473 DOI: 10.1186/s13690-021-00693-2] [Reference Citation Analysis]
2 Isaeva OV, Il'chenko LY, Saryglar AA, Karlsen AA, Kyuregyan KK, Mikhailov MI. [Clinical course and outcomes of chronic viral hepatitis D in patients from Republic of Tuva as endemic region]. Vopr Virusol 2021;66:74-83. [PMID: 33683068 DOI: 10.36233/0507-4088-29] [Reference Citation Analysis]
3 Rizzetto M, Hamid S, Negro F. The changing context of hepatitis D. J Hepatol. 2021;74:1200-1211. [PMID: 33484770 DOI: 10.1016/j.jhep.2021.01.014] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 43.0] [Reference Citation Analysis]
4 Bal T. Siirt İlinde Yüksek Hepatit Delta Antikoru Sıklığı. Düzce Üniversitesi Sağlık Bilimleri Enstitüsü Dergisi. [DOI: 10.33631/duzcesbed.740550] [Reference Citation Analysis]
5 Alfaiate D, Negro F. Update in Drug Development for Chronic HBV/HDV Infection. Curr Hepatology Rep 2019;18:522-530. [DOI: 10.1007/s11901-019-00503-y] [Reference Citation Analysis]
6 Wang Y, Glenn JS, Winters MA, Shen LP, Choong I, Shi YL, Bi SL, Ma LY, Zeng H, Zhang FJ. A new dual-targeting real-time RT-PCR assay for hepatitis D virus RNA detection. Diagn Microbiol Infect Dis 2018;92:112-7. [PMID: 29941366 DOI: 10.1016/j.diagmicrobio.2018.05.016] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Leblebicioglu H, Ozaras R. Hepatitis E virus infection in Turkey: a systematic review. Ann Clin Microbiol Antimicrob 2018;17:17. [PMID: 29716597 DOI: 10.1186/s12941-018-0269-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
8 Elzouki AN, Bashir SM, Elahmer O, Elzouki I, Alkhattali F. Prevalence and risk factors of hepatitis D virus infection in patients with chronic hepatitis B infection attending the three main tertiary hospitals in Libya. Arab J Gastroenterol 2017;18:216-9. [PMID: 29241726 DOI: 10.1016/j.ajg.2017.11.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wranke A, Pinheiro Borzacov LM, Parana R, Lobato C, Hamid S, Ceausu E, Dalekos GN, Rizzetto M, Turcanu A, Niro GA, Lubna F, Abbas M, Ingiliz P, Buti M, Ferenci P, Vanwolleghem T, Hayden T, Dashdorj N, Motoc A, Cornberg M, Abbas Z, Yurdaydin C, Manns MP, Wedemeyer H, Hardtke S; Hepatitis Delta International Network. Clinical and virological heterogeneity of hepatitis delta in different regions world-wide: The Hepatitis Delta International Network (HDIN). Liver Int. 2018;38:842-850. [PMID: 28963781 DOI: 10.1111/liv.13604] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 9.4] [Reference Citation Analysis]
10 Abeywickrama-samarakoon N, Cortay J, Dény P. The hepatitis D satellite virus of hepatitis B virus: half-opening a new era to control viral infection? Current Opinion in Infectious Diseases 2016;29:645-53. [DOI: 10.1097/qco.0000000000000321] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]